<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02061475</url>
  </required_header>
  <id_info>
    <org_study_id>LCLDKY-13115</org_study_id>
    <nct_id>NCT02061475</nct_id>
  </id_info>
  <brief_title>Lidocaine Patches for Attenuating the Pain of Venipuncture Intravenous Cannulation</brief_title>
  <official_title>The Efficacy and Safety of Lidocaine Patches for Attenuating the Pain of Venipuncture Intravenous Cannulation Before Surgery: a Multicenter, Randomized, Double -Blind, Placebo-controled and Parallel-group Designed Clinical Trail</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nitto Denko Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Giant Med-Pharma Services Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Venipuncture and intravenous cannulation are the most common painful procedures, especially
      for the penitents who must receive large diameter venous catheter before surgery. In present
      study we would evaluate the safety and validity of lidocaine patches releasing such pain.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">March 2015</completion_date>
  <primary_completion_date type="Anticipated">March 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The efficiency of lidocaine patches for attenuating the pain of venipuncture intravenous cannulation before surgery</measure>
    <time_frame>Two minters after intravenous cannulation</time_frame>
    <description>VAS score will be evaluated two minters after intravenous cannulation in both group with lidocaine patches or not.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Skin response after intravenous cannulation</measure>
    <time_frame>Thirty minters after intravenous cannulation</time_frame>
    <description>Local skin response to the lidocaine patches will be evaluated thirty minters after intravenous cannulation</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>We Focus on the Pain of Venipuncture and Intravenous Cannulation</condition>
  <arm_group>
    <arm_group_label>Lidocaine Patches</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Patches</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine Patches</intervention_name>
    <arm_group_label>Lidocaine Patches</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who want to participate present study and sign the informed consent form

          -  Age from 18 to 65 years old

          -  Patients who need intravenous cannulation before surgery

          -  ASA class I-II and selected patients

        Exclusion Criteria:

          -  Allergic to lidocaine or any other amide local anesthetics or any other medicine

          -  Allergic skin(allergic to past agent or other topical used medicine)

          -  Skin injured or inflection exist in the local site to patch

          -  Sensation disturbed in any limb

          -  Severe liver and kidney original disease:blood Aspertate aminotransferase and Alanine
             transaminase increased 1.5 times more than normal concentration; blood creatinine is
             higher than the normal range.

          -  Hemoglobin &lt;80g/L

          -  ECG is significantly abnormal

          -  pregnant or possible pregnant or breastfeeding woman

          -  Patient who has consciousness disturbance can not make credible dialog with
             investigator.

          -  Those who are using other medicine may affect the evaluation of present patch

          -  Those who have participated in other clinical trail in the past three months

          -  Those excluded by investigator believed other reasons.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diansan Su, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Renji Hospital, School of Medicine, Shanghai Jiaotong University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Xiangrui Wang, Dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Renji Hospital, School of Medicine, Shanghai Jiaotong University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yanhua Zhao, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Renji Hospital, School of Medicine, Shanghai Jiaotong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diansan Su, Dr.</last_name>
    <phone>0086-21-68383702</phone>
    <email>diansansu@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinmin Wu, Dr.</last_name>
      <phone>0086-10-83572784</phone>
    </contact>
    <investigator>
      <last_name>Xinmin Wu, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guanzhou First people's Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510180</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lixin Xu, Dr.</last_name>
      <phone>0086-20-81048305</phone>
    </contact>
    <investigator>
      <last_name>Lixin Xu, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xiangya Hospital Central South University</name>
      <address>
        <city>Changhai</city>
        <state>Hunan</state>
        <zip>410008</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qulian Guo, Dr.</last_name>
      <phone>0086-731-84327411</phone>
    </contact>
    <investigator>
      <last_name>Qulian Guo, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliate Hospital of Soochow University</name>
      <address>
        <city>Suzhou</city>
        <state>Jiangsu</state>
        <zip>215006</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianping Yang, Dr.</last_name>
      <phone>0086-512-67780149</phone>
    </contact>
    <investigator>
      <last_name>Jianping Yang, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shengjing Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110004</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiuying Wu, Dr.</last_name>
      <phone>0086-24-83955027</phone>
    </contact>
    <investigator>
      <last_name>Xiuying Wu, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhongshan Hospital Affiliated to Shanghai Fudan University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhanggang Xue, Dr.</last_name>
      <phone>0086-21-64041990</phone>
      <phone_ext>3702</phone_ext>
    </contact>
    <investigator>
      <last_name>Zhanggang Xue, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Renji Hospital, School of Medicine, Shanghai Jiaotong University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diansan Su, Dr.</last_name>
      <email>diansansu@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Yanhua Zhao, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai First People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>201620</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shitong Li, Dr.</last_name>
      <phone>0086-21-63240090</phone>
      <phone_ext>3023</phone_ext>
    </contact>
    <investigator>
      <last_name>Shitong Li, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2014</study_first_submitted>
  <study_first_submitted_qc>February 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 12, 2014</study_first_posted>
  <last_update_submitted>August 28, 2014</last_update_submitted>
  <last_update_submitted_qc>August 28, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 29, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lidocaine patches</keyword>
  <keyword>Pain</keyword>
  <keyword>Intravenous cannulation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

